Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psoriasis and the TNF/IL23/IL17 axis
Kazuhisa Furue, Takamichi Ito, Gaku Tsuji, et al.
Giornale Italiano di Dermatologia e Venereologia (2019) Vol. 154, Iss. 4
Closed Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis
Masutaka Furue
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5382-5382
Open Access | Times Cited: 269
Interleukin-17A and Keratinocytes in Psoriasis
Masutaka Furue, Kazuhisa Furue, Gaku Tsuji, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1275-1275
Open Access | Times Cited: 214
Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis
Masutaka Furue, Akiko Hashimoto‐Hachiya, Gaku Tsuji
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5424-5424
Open Access | Times Cited: 166
Current Concepts of Psoriasis Immunopathogenesis
Marijana Vičić, Marija Kaštelan, Ines Brajac, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11574-11574
Open Access | Times Cited: 105
Inflammation context in Alzheimer’s disease, a relationship intricate to define
Catalina Novoa, Paulina Salazar, Pedro Cisternas, et al.
Biological Research (2022) Vol. 55, Iss. 1
Open Access | Times Cited: 89
Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion
H. Bachelez, Juliet N. Barker, A. David Burden, et al.
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 10, pp. 1033-1047
Open Access | Times Cited: 47
Bimekizumab treatment in patients with moderate to severe plaque psoriasis: a drug safety evaluation
Angelo Ruggiero, Luca Potestio, Fabrizio Martora, et al.
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 5, pp. 355-362
Closed Access | Times Cited: 30
Review: A Contemporary, Multifaced Insight into Psoriasis Pathogenesis
Rucsandra Cristina Dascălu, Andreea Lili Bărbulescu, Loredana Elena Stoica, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 5, pp. 535-535
Open Access | Times Cited: 9
Metformin inhibits IL-1β secretion via impairment of NLRP3 inflammasome in keratinocytes: implications for preventing the development of psoriasis
Gaku Tsuji, Akiko Hashimoto‐Hachiya, Yen Hai Vu, et al.
Cell Death Discovery (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 67
Biomarkers of Inflammation in Obesity-Psoriatic Patients
Carmen Rodríguez‐Cerdeira, Mónica Cordeiro-Rodríguez, Miguel Carnero-Gregorio, et al.
Mediators of Inflammation (2019) Vol. 2019, pp. 1-14
Open Access | Times Cited: 62
Gasdermin D (GSDMD) Is Upregulated in Psoriatic Skin—A New Potential Link in the Pathogenesis of Psoriasis
Julia Nowowiejska, Anna Baran, Justyna Magdalena Hermanowicz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13047-13047
Open Access | Times Cited: 19
The Role of Epigenetic Factors in the Pathogenesis of Psoriasis
Joanna Olejnik-Wojciechowska, Dominika Boboryko, Aleksandra Wiktoria Bratborska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3831-3831
Open Access | Times Cited: 6
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study
Francesco Bellinato, Paolo Gisondi, Angelo Valerio Marzano, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 740-740
Open Access | Times Cited: 16
Regulatory Mechanism of the IL-33–IL-37 Axis via Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis
Gaku Tsuji, Kazuhiko Yamamura, Koji Kawamura, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14633-14633
Open Access | Times Cited: 13
Regulating the Polarization of Macrophages: A Promising Approach to Vascular Dermatosis
Huiling Peng, Dehai Xian, Jiexiong Liu, et al.
Journal of Immunology Research (2020) Vol. 2020, pp. 1-13
Open Access | Times Cited: 37
Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin-17 inhibitors and their practical management
Carmen Rodríguez‐Cerdeira, José Luís González-Cespón, Erick Martínez‐Herrera, et al.
Italian Journal of Dermatology and Venereology (2021) Vol. 156, Iss. 5
Closed Access | Times Cited: 32
Natural Compounds Tapinarof and Galactomyces Ferment Filtrate Downregulate IL-33 Expression via the AHR/IL-37 Axis in Human Keratinocytes
Gaku Tsuji, Akiko Hashimoto‐Hachiya, Tomoyo Matsuda-Taniguchi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Integrated bioinformatics combined with machine learning to analyze shared biomarkers and pathways in psoriasis and cervical squamous cell carcinoma
Luyu Liu, Pan Yin, Ruida Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Artemisinin analogues are effective in the treatment of psoriasis by targeting RORγt
Xuyan Tian, Fanrong Peng, X. A. Xiong, et al.
Molecular Immunology (2025) Vol. 180, pp. 11-22
Closed Access
Psoriasis and cancer: the role of inflammation, immunosuppression, and cancer treatment
Manfredo Bruni, Fabio Lobefaro, Cristina Pellegrini, et al.
Expert Opinion on Biological Therapy (2025), pp. 1-17
Closed Access
Association between apical periodontitis and psoriasis vulgaris: A cross‐sectional study
Crystal Marruganti, Giulia Malvicini, Élisa Cinotti, et al.
International Endodontic Journal (2025)
Open Access
Efficacy of interleukin-17 inhibitors in psoriasis patients: a comparative non-randomized study
Olga G. Artamonova, Arfenya Е. Karamova, А. А. Воронцова
Vestnik dermatologii i venerologii (2025)
Open Access
Identification of triazolopyridine derivatives as a new class of AhR agonists and evaluation of anti-psoriasis effect in a mouse model
Chenyu Tian, Guo Zhang, Ziyi Xia, et al.
European Journal of Medicinal Chemistry (2022) Vol. 231, pp. 114122-114122
Closed Access | Times Cited: 18
Double-negative T cells ameliorate psoriasis by selectively inhibiting IL-17A-producing γδlow T cells
Yunxiong Wei, Guangyong Sun, Yang Yang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Dual‐Action Psoriasis Therapy: Antiproliferative and Immunomodulatory Effects via Self‐Locking Microneedles
Ziyi Wang, Ze Qiang Zhao, Yu Sheng, et al.
Advanced Science (2024)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top